Ralf Kronenwett
- Oncology top 1%
- Cancer Research top 0.5%
- Molecular Biology top 5%
- Immunology top 2%
- Hematology top 1%
- Co-authors
- Rainer HaasCarsten DenkertManfred DietelBerit MüllerSibylle LoiblSilvia Darb‐EsfahaniGϋnter von MinckwitzWilko Weichert
- Topics
- Breast Cancer Treatment Studies (46 papers)Advanced Breast Cancer Therapies (26 papers)HER2/EGFR in Cancer Research (22 papers)
- Cited by
- Cancer ResearchOncologyHematology
- Journals
- Nucleic Acids ResearchJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Ralf Kronenwett
128 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 2.6k
- Cancer Research 1.8k
- Molecular Biology 1.5k
- Immunology 1.1k
- Hematology 831
Countries citing papers authored by Ralf Kronenwett
This map shows the geographic impact of Ralf Kronenwett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Kronenwett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Kronenwett more than expected).
Fields of papers citing papers by Ralf Kronenwett
This network shows the impact of papers produced by Ralf Kronenwett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Kronenwett. The network helps show where Ralf Kronenwett may publish in the future.
Co-authorship network of co-authors of Ralf Kronenwett
This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Kronenwett. A scholar is included among the top collaborators of Ralf Kronenwett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Kronenwett. Ralf Kronenwett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 62 | |
| 3 | 57 | |
| 4 | 8 | |
| 5 | 204 | |
| 6 | 152 | |
| 7 | Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial. | 6 |
| 8 | 107 | |
| 9 | 235 | |
| 10 | 0 | |
| 11 | 13 | |
| 12 | 129 | |
| 13 | 19 | |
| 14 | 25 | |
| 15 | 61 | |
| 16 | 47 | |
| 17 | 28 | |
| 18 | 39 | |
| 19 | 68 | |
| 20 | 10 |
About Ralf Kronenwett
Ralf Kronenwett is a scholar working on Cancer Research, Hematology and Oncology, having authored 131 papers that have together received 5.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (46 papers), Advanced Breast Cancer Therapies (26 papers) and HER2/EGFR in Cancer Research (22 papers). The work is most often cited by research in Cancer Research (1.8k citations), Oncology (2.6k citations) and Hematology (831 citations). Ralf Kronenwett has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Rainer Haas, Carsten Denkert, Manfred Dietel, Berit Müller, Sibylle Loibl, Silvia Darb‐Esfahani, Gϋnter von Minckwitz, Wilko Weichert, Knut Engels and Christine Solbach. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.